Xingyu Wang

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

Johannes F.E. Mann, Roland E. Schmieder, Matthew McQueen et al. · The Lancet · 2008 · 1.6K citations

Medicine, Nephrology, Pharmacotherapy +12

Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups

Guillaume Paré, Artuela Çaku, Matthew McQueen et al. · Circulation · 2019 · 391 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Single-cell transcriptional profiles in human skeletal muscle

Aliza B. Rubenstein, Gregory R. Smith, Ulrika Raue et al. · Scientific Reports · 2020 · 339 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians

Ganesan Karthikeyan, Koon Teo, Shofiqul Islam et al. · Journal of the American College of Cardiology · 2009 · 214 citations

Medicine, Cardiology, Epidemiology +15

Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk

Sheldon W. Tobe, Catherine M. Clase, Peggy Gao et al. · Circulation · 2011 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16